Delivery Order SPE2DB20D3111-SPE2DB25FA9NB
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $31,963.51 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets (30-count units) with a firm fixed price structure. This non-set-aside contract, awarded on June 18, 2025, is scheduled for completion by June 20, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in the treatment of HIV, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside delivery order carries a ceiling value of $15,248.99 and is scheduled for completion by August 12, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The delivery...
- The Defense Logistics Agency awarded a $20,611.42 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price contract with no set-aside designation, utilizing competitive procurement procedures. The contract is set to be completed by August 13, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Biktarvy is a prescription...
- The Defense Logistics Agency awarded a delivery order valued at $39,414.39 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price, competitively awarded delivery order represents a non-set-aside procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in the...
- The Defense Logistics Agency awarded a $13,093.45 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This contract, which is firm fixed price and non-set-aside, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery location is specified as Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025....
- The Defense Logistics Agency awarded a delivery order valued at $10,527.73 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on September 17, 2025, with an ultimate completion date of September 18, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in HIV treatment, and this order supports...
- The Defense Logistics Agency awarded a delivery order valued at $8,351.68 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This firm fixed price delivery order, with a completion date of July 30, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in HIV treatment, reflecting the...
- The Defense Logistics Agency awarded a $10,155.16 delivery order to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) with a firm fixed price contract type and completion date of September 4, 2025. This non-set-aside competitive award was issued to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania on September 3, 2025. Biktarvy is an antiretroviral medication used in HIV treatment, representing part of the broader...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $55,124.14 and an ultimate completion date of August 29, 2025. The contract involves no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $26,682.54 and an ultimate completion date of August 11, 2025. The contract was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB25FA9NBDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This non-competitive delivery order, valued at $7.6K, represents a firm fixed-price pharmaceutical procurement under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is scheduled for completion by September 18, 2025, with performance at the vendor's corporate headquarters in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used for HIV treatment, reflecting the federal government's ongoing pharmaceutical supply needs for military and veteran healthcare systems. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's broader $1 billion IDC with DLA Troop Support Medical (contract SPE2DX), which extends through December 2026 and provides comprehensive global pharmaceutical support to military healthcare programs worldwide. AmerisourceBergen, one of the nation's largest pharmaceutical distributors, maintains a significant presence in federal medical procurement and supplies a wide range of brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. The company's contract portfolio demonstrates its capability to meet federal procurement requirements through competitive processes, supporting critical healthcare initiatives for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 9/17/25 |